Biofield may double within 3 months! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biofield may double within 3 months!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robin who wrote (33)	1/2/1997 3:39:00 AM
From: damniseedemons	of 120

I actually still like BZET for purchase. This new scanner is going to be a dynamite product (assuming that it gets approved--which it probably will). Women don't like mammograms (for one thing, they hurt). With Biofield's non-invasive, quick&easy procedure, that might actually be better than a mammogram, the company (hence, the stock) should really do well. I'm not sure I'd run-out and buy the stock tomorrow (profit-taking is possible over the next day(s)). However, BZET is definately a stock I'd like to own before H&Q Jan 6-9 conference. This is a huge institutional conference. And as I've said before, Biofield is going to present their [impressive] data from the European trials at that time. My $20 price target for BZET, is for AFTER their H&Q presentation. Sal Habash P.S. AMD at $70? Not unless Intel decides to close-up shop!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next